ML, C., Z, Z., DB, D., RR, M., SK, L., X, Z., . . . ML, S. (2026). Covalent inhibitor design confers activity against both GDP- and GTP-bound forms of KRAS G12C. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-69003-0
Chicago Style (17th ed.) CitationML, Condakes, et al. "Covalent Inhibitor Design Confers Activity Against Both GDP- and GTP-bound Forms of KRAS G12C." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-69003-0.
MLA (9th ed.) CitationML, Condakes, et al. "Covalent Inhibitor Design Confers Activity Against Both GDP- and GTP-bound Forms of KRAS G12C." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-69003-0.
Warning: These citations may not always be 100% accurate.